Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Iron replacement therapy in the management of anaemia in non-dialysis chronic renal failure patients: Perspective of the Spanish Nephrology Society Anaemia Group.
Cases A, Puchades MJ, de Sequera P, Quiroga B, Martin-Rodriguez L, Gorriz JL, Portolés J; en representación del Grupo de Anemia de la S.E.N.. Cases A, et al. Among authors: quiroga b. Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):123-136. doi: 10.1016/j.nefro.2020.11.003. Epub 2021 Jan 28. Nefrologia (Engl Ed). 2021. PMID: 33516607 Free article. Review. English, Spanish.
Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.
Goicoechea M, Sanchez-Niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-Juarez G, de Sequera P, Verdalles U, Verde E, Luño J. Goicoechea M, et al. Among authors: quiroga b. Prostaglandins Leukot Essent Fatty Acids. 2017 Oct;125:8-13. doi: 10.1016/j.plefa.2017.08.009. Epub 2017 Aug 24. Prostaglandins Leukot Essent Fatty Acids. 2017. PMID: 28987723 Clinical Trial.
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J. Goicoechea M, et al. Among authors: quiroga b. Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1. Cardiovasc Drugs Ther. 2018. PMID: 29943364 Clinical Trial.
Onco-Nephrology: Cancer, chemotherapy and kidney.
de Francisco ALM, Macía M, Alonso F, García P, Gutierrez E, Quintana LF, Quiroga B, Torregrosa I. de Francisco ALM, et al. Among authors: quiroga b. Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):473-481. doi: 10.1016/j.nefro.2018.10.016. Epub 2019 Mar 29. Nefrologia (Engl Ed). 2019. PMID: 30929891 Free article. Review. English, Spanish.
Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant.
de Sequera Ortiz P, Quiroga B, de Arriba de la Fuente G, Macía Heras M, Salgueira Lazo M, Del Pino Y Pino MD; en representación de la Sociedad Española de Nefrología. de Sequera Ortiz P, et al. Among authors: quiroga b. Nefrologia (Engl Ed). 2020 May-Jun;40(3):253-257. doi: 10.1016/j.nefro.2020.03.001. Epub 2020 Apr 2. Nefrologia (Engl Ed). 2020. PMID: 32249016 Free PMC article. English, Spanish. No abstract available.
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy.
Goicoechea M, Gomez-Preciado F, Benito S, Torras J, Torra R, Huerta A, Restrepo A, Ugalde J, Astudillo DE, Agraz I, Lopez-Mendoza M, de Arriba G, Corchete E, Quiroga B, Gutierrez MJ, Martin-Conde ML, Lopes V, Ramos C, Mendez I, Cao M, Dominguez F, Ortiz A; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Goicoechea M, et al. Among authors: quiroga b. Nefrologia (Engl Ed). 2021 Mar 10:S0211-6995(21)00031-X. doi: 10.1016/j.nefro.2021.01.002. Online ahead of print. Nefrologia (Engl Ed). 2021. PMID: 33714629 Free article. English, Spanish.
134 results